autism prevalence usanac.nationalautismassociation.org/wp-content/uploads/2019/05/ohar… · Ø the...
TRANSCRIPT
5/17/19
1
NAA May, 2019
Nancy Hofreuter O’Hara, MD, MPH, FAAP
www.drohara.com
What’s Next?
Moving Forward:
Therapies to Consider
and Why
Autism prevalence USA
5/17/19
2
The Yin and Yang Between Tolerance and Immune Response Leading To Autoimmunity
EnvironmentalFactors
HumanGenome
ClinicalOutcome
IncreasedGutPermeability
Microbiome
ImmuneResponse
“Now another concept may be emerging, which might be called the ‘keystone
relationship’. “The interaction between fiber and microbes that consume it, is the
fundamental keystone interaction that everything else is built on in the gut. It may lie
at the heart of the symbiotic pact between microbes and humans.”
Nature 518, S3–S11 (26 February 2015)
5/17/19
3
New Discoveries -> Paradigm Shifts
Vs Status Quo and Denials
� Problem: Doctors give names to things they don’t understand so they can start the process of understanding.
� Bigger problem: Naming something gives the impression we understand it.
� Quotes: � – “Your blood sugar is high because you have diabetes.”
� – “You feel sad because you have depression.” � – “Your blood pressure is high because you have hypertension.” � – “You have pain and feel sick because you have post-treatment Lyme disease
syndrome.” � – “Your son can’t speak because he has autism.”
� How do you escape these misleading fallacies?
� – Find the root cause of the disease (not just the symptoms) and direct new treatments at the root of each illness.
� • Maybe there is a common cause for many chronic illnesses.
The Cell Danger Response � First wave of danger signals
� Release of metabolic intermediates such as � ATP, ADP � Krebs cycle intermediates � Reactive oxygen species
AND is sustained by purinergic signaling extracellularly
� After the danger has been eliminated -> choreographed sequence of anti-inflammatory and regenerative pathways activated – HEALING
� Abnormal persistence of CDR -> disturbance in whole body metabolism, gut microbiome, multiple organ performance, behavior changes -> chronic disease
5/17/19
4
Persistent Cell Danger Response Abnormal Purinergic Signaling in ASD
� Cell Danger Respone (CDR) – evolutionarily conserved metabolic response that protects cells and hosts from harm.
� Triggered by encounters with chemical, physical, or biological threats that exceed the cellular capacity for homeostasis.
� In ASD and other chronic illnesses -> Persistent Cell Danger Response
Abnormal Purinergic
Signaling in ASD
5/17/19
5
Anti-Purinergic Therapy
• Phase I clinical trial - safety and tolerability of a single dose of suramin in children with autism. Randomized, double-blind, placebo controlled; 10 boys; 5-14 years with ASD
• Hypothesis: Hyperpurinergia is a core feature of ASD; single dose of antipurinergic therapy with suramin can temporarily reverse some of the speech, social, & ANS deficits in ASD
• Intervention: Single dose of suramin administered IV
• Outcomes: Statistically significant improvement in CGI, OCD, social interactions, expressive language; dozens of metabolic abnormalities improved
• Each treated child -> non-core symptom improvements (none in placebo group)
– Accelerated developmental and learning milestones
– Decreased anxiety and meltdowns in novel situations
– Improved sleep and interest in new foods
– Improved GI function (suramin restored microbiome diversity in mice)
Mindd International Forum 31
Dozens of Metabolic Abnormalities were Improved by One Treatment
MIA
OxalateB2-Riboflavin
Biopterin
GABA/GluBioamines*Trp/5HT/KynurenineAmino sugars
PurinesBile acids
MicrobiomePhospholipids
SAM/SAH/GSHPyrimidinesGlycolysis
SphingomyelinsCeramides*CholesterolKrebs cycle
Eicosanoids*Fatty acid oxidation
Cardiolipin*Glycosphingolipids*Branch Chain AA
NO/ROS
Pentose PhosphatePropionate (IVTM)
B6-Pyridoxine
Fragile X
Human ASD
21%
40%
g-Glutamyl DipeptidesTaurine*, Histamine
Vitamin C, D*, Phe/Tyr1-Carbon/Folate
Myoinositol*
25%
14%
75% Shared withMouse Models
Before6-Weeks
Before6-Weeks0
2
4
6
8
10
ADOS
Com
pariso
n Scor
e
Suramin Treatment Improved ADOSScores by 1.6 Points in 6 Weeks
Suramin
Placebo
ASDNot ASD
3 doses in3 months?
Suramin Placebo
1.6 ± 0.55(p < 0.0028)
0.4 ± 0.55(p = ns)
Suramin Treatment Decreased Autism Core Symptoms Significantly in 6 weeks
62
Off spectrum?
5/17/19
6
Metabolic Features of the CDR and Its Evolutionary Origins in the Seasons
From Naviaux RK. Metabolic Features of the Cell Danger Response. Mitochondrion, 2013.
(Scarce Calories)
(Plentiful Calories)
The Persistent Cell Danger Response
� For More Information
� • PubMed:
� – The Metabolic Features and Regulation of the Healing Cycle. Naviaux RK. Mitochondrion, September 2018. <-- Read this one first.
� – Incomplete healing as a cause of aging. Naviaux RK. Biology MDPI, 2019.
� – Antipurinergic Therapy for Autism. Naviaux RK. Mitochondrion, December 2017.
� – The Suramin Autism Treatment I Trial. Ann Clin Trans Neurol, Naviaux RK, et al., 2017.
� • Website: http://naviauxlab.ucsd.edu
5/17/19
7
The changing face of gut microbes
• The human gut harbors 1011-1012 bacteria per gram colonic content (>1014 total bacteria); • Total bacteria outnumber human cells 10:1; • Total bacterial genes outnumber human genes >150:1; • >10,000 different species of bacteria are resident in the human intestinal microbiota (400-500 per person)
The Epidemics of Immune-Mediated Diseases In The Western Hemisphere: The Hygiene Hypothesis
5/17/19
8
RESTORING THE BIOME: HELMINTHS For A HEALTHY
IMMUNE SYSTEM
You are 10% YOU
The adult human body has about 10 trillion cells (with
your own DNA)
The adult human body has about 100 trillion other
organisms…with their own DNA
YOU ARE AN ECOSYSTEM
So what happens if you change even one element in an ecosystem?
Reintroduction of wolves to Yellowstone National Park
Wolves reduced the elk population
The elk had been eating the willows
With more willows -> more beavers
Beavers built dams -> changed stream hydrology
Changes in the water and ecosystem!
5/17/19
9
Now let’s look at the YOU In the last 100 or so years, we completely
changed our evolutionary-history lifestyles: � Started to use toilets � Started wearing shoes everywhere, all the time � Started eating highly processed foods � Started drinking processed water � Stopped regularly breastfeeding � Started to use antibiotics � Started doing c-sections more and more � Started wearing sunscreen and working indoors
more often � Etc. etc. etc.
Why HDC is Our Organism of Choice Ø The low cost of cultivation facilitates its use for
normalization of the immune system by the population as a whole. ($)
Ø No transmission from human-to-human is possible
Ø The distribution of the HDCs in the human body is strictly limited to the lumen (inside) of the gut, unlike nematodes currently in use (hookworms and whipworms) which breach the barrier of the gut. Minimal risk of infestation.
Ø HDCs are raised in grain beetles (Tenebrio molitor), which are normally found in the human food supply as a harmless contaminant in a wide variety of grains.
Ø HDC is a mutualist! NOT A PARASITE!
Ø HDCs evoke an immune system response which we NEED as it is a normal part of our immune conditioning.
Ø www.biomerestoration.com
5/17/19
10
Biome depletion results in increased inflammation (Molecular & Biochemical Parasitology (2009) 167: 1–11)
Concerns � Post HDC inflammatory reaction
� Start with lower dose HDC � Increase q 3 wks � Ibuprofen � Antihistamine
� Infestation � Constipation/Slow transit time � Immunocompromised status or medications � Symptoms – severe cramping and pain � Treatment – billtiricide 20 mg/kg/day divided into 3 doses
treats infestation
5/17/19
11
Additional thoughts � Chance of infestation 0.1% in children
� Increased chances of colonization with immunosuppression and being a child
� Tapeworm colonizations are notoriously asymptomatic, although abdominal pain can sometimes occur
� Sometimes the eggs get released sporadically or in “bursts” - important to do repeated stool checks to make sure that there are no adults present
� The HDC organisms are not like bacteria in the sense that they don’t multiply inside the body. Thus they cannot adapt like bacteria. All are sensitive to Billtricide
� Why HDCs? � Microbiome diversity � Changes in immune function � Reduction of total toxic load � Return to preindustrial tolerance
TheSandwich
Whilesomewouldsaythat“everythingisautoimmuneuntilprovenotherwise”readingthechaptersinthisbookwrittenbyworldleadersinautoimmunitybringsonetotheconclusionthateverythingafterallisinfectiousuntilprovenotherwise(includingautoimmunediseases).
RoseNE,Shoenfeld Y(Editors)InfectionandAutoimmunity,2005
“Everything is autoimmune until proven otherwise” and everything after all is infectious until proven otherwise (including autoimmune diseases). Rose NE, Shoenfeld Y Infection and Autoimmunity, 2005, p 1
What Dr. Shoenfeld says is that common sense demands a trial of safe measures to restore immune tolerance in all complex chronic illnesses.
Sid Baker’s guru
5/17/19
12
The Microbiome as Possible Transducer of All Environmental Factors Affecting Onset of CID in
Genetically Susceptible Individuals
Martin VJ, et al J Pediat 2016 Sept 12, (Epub ahead of print)
Dysbiosis is one of the key factors causing zonulin release and subsequent loss of
barrier function
© MAPS 2013
5/17/19
13
Chronic Inflammatory Response Syndrome � Studied and researched by Ritchie Shoemaker (Pokomoke, MD –
Pfiesteria outbreak -> watermen ill with biotoxin illness improved with CSM); Continued research by Neil Nathan
� Genetic susceptibility and exposure to biotoxins � Failure to mount an effective immune response to biotoxins � Neuroimmune, vascular, endocrine dynamics � Linked to Aspergillus, Penicillium, Chaeitomium, Wallemia,
Borrelia, Babesia, Bartonella, Anaplasma and Ehrlichia
� Biotoxin driven multisystem and multisymptom pathway Berndtson, CIRS:Overview,Diagnosis and Treatment, 2013
Enter Fat Cell
Mycotoxins Activates NF Kappa
B
Binding releases
2nd Messenger
• Turns on gene transcription
• Cytokine production
Moves into Nucleus
CIRS � History, signs, symptoms consistent with biotoxin exposure
� CIRS-causing biotoxins are ionophores, disrupt nerve function
� Exposure to toxin-producing molds documented by EPA-approved ERMI test
� Genetic predisposition – HLA susceptibility (HLA DRB and DQ) � 25% population genetically prone � 2% highly susceptible to disabling symptoms
� Warming campfire becomes devastating wildfire (N Nathan)
� Biomarkers consistent with abnormalities in following systems � Neurologic (neurotoxins first and foremost) � Immunologic � Vascular (cardiovascular and GI – ANS connections) � Endocrine Shoemaker et al, Env Health Pers, 2001
Block Leptin
Receptors Cytokines
To override creating Leptin
resistance
Fat cells produce
more Leptins
Critical regulators of neurologic,
immunologic, endocrine function
Hypothalamus no longer
makes MSH, VIP
5/17/19
14
© MAPS 2013
CIRS - It is not just Mold � Mold spore fragments
� Volatile Organic Compounds (VOCs)
� Microorganisms (Actinomycetes, Mycobacteria, Lyme)
� Beta glucans, hemolysins, mannans, proteinases
� THINK CIRS when you hear (pathognomonic) � Electric shock sensations � Ice pick or lightening bolt pains � Pulsing or vibrating sensations (especially down spine)
5/17/19
15
Visual Contrast Sensitivity � Biotoxin exposure can impair
� Optic nerves � Ability to see patterns impaired
� 98% who fail VCS & have 8 sxs � Have a biotoxin illness
� Fail if NOT reach lower line � Nothing visible in Row E � Barely able in Row D � Test failed = biotoxicity Interpretation – note hand drawn checks & ovals
Check = black and white component seen clearly Oval means component not seen from TOXIC by Neil Nathan, MD Forward by Robert Naviaux, MD, PhD
Mycotoxin Testing � Real Time or Great Plains urine testing
� Best done after � Two week course of oral glutathione � IV glutathione � Sauna
� Watch for worsening of symptoms during challenge
� More specific and less invasive testing
� May worsen as start treatment � N of 1 (testing as guide)
5/17/19
16
CIRS Diagnosis � Detailed history of exposure and symptoms
� Visual contrast testing deficit – monitor changes over treatment course
� Check HLA susceptibility and appropriate biomarkers (MSH, VEGF, TGF-beta, Leptin) and/or urine mycotoxin testing
� Check MARCoNS NASAL SWAB (may need to check family dog!) � Treat with nasal spray if positive (1 squirt/nostril 2x/day) � BEG – Bactroban 0.2%, EDTA 1%, Gentamicin 0.025%, additions
� Run ERMI tests (home, office, school, other) – vacuumed dust examined for 36 mold toxins
� Shoemaker and House, 2006
CIRS Treatment Steps � Remove from exposure and retest (ERMI vs HERTSMI-2)
� Preload with EFAs 3-4 grams/day for at least 5 days
� CSM/Welchol/Binders (Charcoal, Zeolite) - COMPOUNDED
� Eradicate MARCoNs
� Correct Antigliadin antibodies; remove gluten
� Rebooting and Reassessing (metabolic, immunologic, gut…) � Sleep, exercise, meditation and DIET! � Probiotics, prebiotics, antioxidants (vitamin D, GSH, oils…) � Minerals – zinc, magnesium � Mitochondrial support
5/17/19
17
CIRS Treatment � Antifungals – oral and intranasal
� Binders (depending on mycotoxin results) � Cholestyramine (compounded) – best for Ochratoxins � Charcoal – best for Aflatoxins � Chlorella and bentonite clay (limited information) – consider with
charcoal for Trichothecenes
� Additional agents � Glutathione and N-acetyl cysteine – consider for Gliotoxins � S Boulardii – consider for Gliotoxins � DHEA � Glutamate modulators - consider lamictal, Topamax, Gabapentin,NAC,
Amantadine, Strattera, Dextromethorphan, Huperzine A, Butyrate (gammahydroxy butyrate), Cannabinoid
CIRS • Think CIRS
• Symptoms in 6 clusters • Commonly up to 10
5/17/19
18
Excellence is the result of caring more than others think is wise, risking more than others think is safe, dreaming more than others think is practical and expecting more than others think is possible
CBD and Hemp Oils
� CBD (Hemp Oil) – Cannabidiol � Reverses mCPP-induced marble burying in mice
� Nardo et al, 2013; Delana et al, Psychopharm, 2012
� Nonpsychoactive, anxiolytic, antipsychotic
� Decreases inflammation and pain
� Anticonvulsant
� Multiple brands (test at Proverde in Milford, MA; www.proverdelabs.com)
5/17/19
19
CORTISOL
� Elevation - associated with Insomnia, decreases the amount and quality of REM sleep
� Increases pro-inflammatory cytokines à INFLAMMATION
� Prolonged elevated cortisol increases risk for chronic illnesses
� Elevated cortisol decreases TSH and ability for proper conversion of T4 à T3
� Elevated cortisol - Decreases mitochondrial energy production capacity à MITOCHONDRIAL DYSFUNCTION
� Elevated cortisol -> � Insulin receptor insensitivity � Insulin resistance
• Carlsson et al. Psychological stress in children may alter the immune response. J Immunol. 2014. • Moreyet al. Current Directions in Stress and Human Immune Function. Current opinion in
psychology 2015. Van Cauter et al. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels. JAMA. 2000.
• Walter et al. Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women. Thyroid Research 2012.
• Picard et al. Psychological Stress and Mitochondria: A Systematic Review Psychosomatic medicine. 2018 • Geer, Eliza B et al. “Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue
function and lipid metabolism” Endocrinology and metabolism clinics of North America . 2014.
5/17/19
20
SUPPORTING THE ADRENALS � Ashwaganda – calming, thyroid support
� Rhodiola – fatigue, enhances endurance, situational anxiety, mental clarity, inflammation
� Gotu Kola – ADHD, mental chatter
� Holy Basil – blood sugar regulation, metabolic syndrome
� Siberian Ginseng – improves fatigue, concentration, enhances oxygen metabolism, etc.
� Licorice – hypoadrenalism, fatigue, antiviral
� Healthy, well balanced, organic, non-processed diet
� Exercise – to the point of sweating! Plus spend time outdoors!
� Meditation, relaxation techniques, mantras, tapping, sleep hygiene
� IONCLEANSE BY AMD
MEASURING EFFECTS OF IONCLEANSE BYAMD ON CORTISOL LEVELS IN CHILDREN
WITH ASD
� Clinically, we were seeing that the IonCleanse by AMD decreases stress and sensory overload (specifically sound sensitivity) in children with ASD, particularly children of adolescent age
� Lead us to conduce a small study in our office
� The sample included 10 children with a diagnosis of ASD between the ages of 6 – 19 years old (mean = 12 years old).
� Participants were chosen based on ASD diagnosis and clinical symptoms consistent with stress and suspected adrenal dysfunction.
� Inclusion criteria included at least one symptom of the following: sleep disturbances, anxiety, sensory overload, hyperactivity, OCD, perseverations, aggression, and self-injurious behavior.
5/17/19
21
MEASURING EFFECTS OF IONCLEANSE BY AMD ON CORTISOL LEVELS IN
CHILDREN WITH ASD � Cortisol was collected by blood and saliva.
� AM fasting blood cortisol � 4 point saliva cortisol - AM, afternoon, late afternoon, evening � Tests were done 7 days before the introduction of the IonCleanse footbath and 7 days
after the 60-trial period.
� Parents of the participants listed the top 3-5 symptoms for which they would like improvement at the beginning of the study. Each week parents were required to submit a parent observation sheet ranking the prevalence of the initial symptoms reported. � The scale was from 0-12 (0-3 minor, 4-8 moderate, 9-12 severe).
� The footbaths were done on the schedule of 2 days on, 1 day off for a 60-day period.
� The length of time for the footbaths were dependent on the participants age.
� 60-day, 100% money back guarantee; no forms, no restocking fees, etc
0
5
10
15
20
25
30
6 y/o M
9 y/o. F
19 y/o M
12 y/o F
11 y/o M
11 y/o M
10 y/o M
14 y/o M
10 y/o M
Pre IonCleanse AM (nmol/L) Post IonCleanse AM (nmol/L)
0
5
10
15
20
25
6 y/o M
9 y/o. F
19 y/o M
12 y/o F
11 y/o M
11 y/o M
10 y/o M
14 y/o M
10 y/o M
Pre IonCleanse Afternoon (nmol/L)
Post IonCleanse Afternoon (nmol/L)
0
2
4
6
8
10
12
14
6 y/o M
9 y/o. F
19 y/o M
12 y/o F
11 y/o M
11 y/o M
10 y/o M
14 y/o M
10 y/o M
Pre IonCleanse Late Afternoon (nmol/L)
Post IonCleanse Late Afternoon (nmol/L)
0
2
4
6
8
10
12
6 y/o M
9 y/o. F
19 y/o M
12 y/o F
11 y/o M
11 y/o M
10 y/o M
14 y/o M
10 y/o M
Pre IonCleanse Evening (nmol/L) Post IonCleanse Evening (nmol/L)
SALIVARY CORTISOL AM RESULTS
SALIVARY CORTISOL AFTERNOON RESULTS
SALIVARY CORTISOL LATE AFTERNOON RESULTS
SALIVARY CORTISOL EVENING RESULTS
5/17/19
22
RESULTS � Blood cortisol and salivary cortisol results were not statistically
significant. Likely due to extremely small sample size.
� There were benefits reported on the parent observation sheets (i.e attention, sleep disturbances, fatigue, eye tics, rigidity, and bruxism).
� Some children experience severe herxheimer reactions
� 1/3 of the participants purchased the the IonCleanse unit after the end of study to continue treatment based on the benefits seen.
� Future Plans: Phase II to include a larger sample size with stricter regulations in sample collection and inclusion criteria and including biochemical, inflammatory and metabolic markers.
AUTISM Autism– TMR Study
� Autism Treatment Evaluation Checklist(ATEC)changes analyzed by The Thinking Moms Revolution
� 27 participants
� 4 months of use – 3 days of cleansing, 1dayoff,repeat
� Results:55% Average ATEC Reduction
� (64% for Teenagers)
5/17/19
23
GLYPHOSATE Glyphosate Evaluation
� 2018
� Great Plains Labs
� Measure of glyphosate excretion in urine
� 30 day period
� 9 in control
� 10 in therapy group � 12 sessions (M,W, F)
Control IonCleanse Therapy
-14%
-48%
Glyphosate level vs. baseline test
“Follow those who seek the truth but flee from those who have found it.”
Yaclav Havel/Andre Gide
5/17/19
24
Stem Cell Therapy
� Mechanisms of underlying therapeutic effects � Immunomodulatory properties – change in
proinflammatory and anti-inflammatory cells � Paracrine effect (cytokines, chemokines, growth factors
and restoration of injured tissues)
� Stem Cell Types � Fetal � Bone marrow derived � Adipo � Umbilical cord and amniotic
Stem Cell Therapy & Animal Models � Beneficial effects in mouse models
� Improved repetitive behaviors � Decreased cognitive rigidity � Improved social interactions � Improved hippocampal neurogenesis
� Segal-Gavish et al. Mesenchymal stem cell transplantation promotes neurogenesis and ameliorates autism related behaviors in BTBR mice. Autism Res. 2016
� Perets et al. Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autism. Behav Brain Res. 2017
5/17/19
25
Stem Cell Therapy and Clinical Trials
� Improvements in social relationships and reciprocity
� Improvements in cognitive aspects (attention, concentration, and time of response)
� Improvements in speech and language patterns
� Trophic and induction changes not cell replacement � Sharma A, Gokulchandran N, Sane H, et al. Autologous bone marrow mononuclear cell
therapy for autism: an open label proof of concept study. Stem Cells Int. 2013 � Dawson G, Sun JM, Davlantis KS, et al. Autologous cord blood infusions are safe and
feasible in young children with autism spectrum disorder: results of a single-center Phase I open-label trial. Stem Cells Transl Med. 2017
� Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 2008
What lies behind us and what lies before us are small matters compared to
what lies within us.
5/17/19
26
MICROBIALCOMMUNITIESINASDAREDIFFERENTFROMTHOSEIN
CONTROLS RoseD.R.etalBrain,Behav,immun2018
52
Behavioral Measures In ASD Children +/- GI Symptoms
RoseD.R.etalBrain,Behav,immun2018
5/17/19
27
FMT - Background � Short-term benefit from oral vancomycin treatment of regressive-
onset autism (Sander et al J Child Neurol 2000) � Killing off bacteria (good, bad and ugly) � Initial hyperactivity, then temporary gains � Lost all gains after stopping treatment
� Children with ASD who had GI symptoms � Higher ATEC scores (speech, social, cognitive, sensory issues)
� Lower microbial diversity in children with ASD (Kang et al 2013) � Low levels of Prevotella (higher if high fiber diet) � Lower butyrate (starving for fiber)
FMT - Autism � FMT for Clostridia Difficile (one fecal transplant)
� Dr. Thomas Borody (GI from Australia) used FMT in ~ 5000 patients, including 9 children with autism for 3 months � Improved bowel function and sleep � Increased vocabulary, attention and task performance
� Initial study protocol at Arizona State University � 2 weeks oral vancomycin � 1 day fasting and bowel cleanse � High dose, highly purified microbiota (oral or rectal) � 7-8 weeks low dose microbiotia (different donor)
5/17/19
28
Fecal Transplants – FMT Adams et al. Arizona State University. Scientific Reports. 2017
� What they did � 18 children with ASD & moderate/severe GI sxs (aged 7 to 16) received MTT � 20 equivalent control subjects who had neither gut problems nor ASD diagnosis � Both groups were treated for 10 weeks & follow-up testing for a further 8 weeks
� What they found � Mothers with ASD and GI sxs (low maternal fiber, lower rate BF, higher rate C section birth
and increased antibiotic use) � Fewer gut problems (80% reduction in symptoms) – better with oral than rectal � Ongoing improvements in ASD symptoms two years after procedure (58% reduction in
symptoms)
� Originally ASD symptoms eased or vanished for at least a couple of months after treatment ended (at least 47% overall reduction)
� After 2 years, diversity even higher & the presence of beneficial microbes remained (4 fold increase Bifidobacterium and 84 fold increase in Prevotella)
FMT – What’s Available � FMT
� Need more trials as “poop is a drug” � Only allowed for recurrent C Diff
� Ongoing studies (Phase 2) � New Child Study - pending funding � Adult study – Treating Adults with ASD (Adams and Frye)
� Randomized, double blinded, placebo controlled
� Open Biome � Capsules and by endoscopy or colonoscopy � Only available to gastroenterologists and infectious disease
specialists & must have documented C Difficile
� Home use – BE CAREFUL! � Need clean, healthy donor & oral route better
5/17/19
29
CNS & Neurological Disorders - Drug Targets, 2015, 14, 110-131
Evidence obtained from human and animal studies provides a unifying paradigm of a vicious cycle in that:
changes in gut flora dysbiosis gut inflammation gut dysfunction (intestinal permeability) systemic inflammation neuroinflammation, disparate pathophysiological alterations including behavioral changes (Fig. 1).
Altered Mucosal Integrity
Poor dietary choices
Altered Intestinal
Permeability
Stress
Infection
Dysbiosis
Inflammation
Systemic Disease
Low Stomach Acid
Toxic Exposure
Ischemia, low O2
Food Allergy, Sensitivity, &
Intolerance
Malnutrition
Toxic Overload
Elevated Total Toxic &
Antigenic Burden
Systemic Disease
WHAT DO WE DO???
5/17/19
30
Suzuki et al, Cell Mol Life Sci, 2013
Antoine Louveau, Structural and functional features of central nervous system lymphatic vessels, Nature 523, 337-341
Value of Sleep: Detoxification � Sleep deprivation stressed the immune
system like physical stress or illness
� The brain has a unique waste management system - glymphatic system - which is active during sleep
� The glymphatic system pumps cerebral spinal fluid through your brain’s tissues, flushing the garbage from your brain into your bloodstream and into your liver, for elimination
� Your brain cells also shrink about 60 percent during sleep for more efficient waste removal
� Atlas Orthogonal Chiropractic Manipulation
� Vagal Nerve Stimulation
5/17/19
31
The “Anti-Inflammatory” Diet
The Human race appears on the face of hearth
Years
2.5 M
DietFruits, nuts, tubers
Occasional meat
Change from nomadic tosettled life style
10,000
Advent of agricultureDevelopment of gluten
containing grains
2009The Human race appears
on the face of hearth
Years
2.5 M
DietFruits, nuts, tubers
Occasional meat
Change from nomadic tosettled life style
10,00010,000
Advent of agricultureDevelopment of gluten
containing grains
2009
5/17/19
32